Positive mid-stage results with Apogee Therapeutics' IL-13 inhibitor APG777 in atopic dermatitis have driven the company's shares up around 20%, as it prepares for a phase 3 programme. The 16-week ...
Looking for your next gig? We’ve rounded up the best worldwide casting calls actively searching for talent. This week, find casting notices for a high-paying international e-mobility campaign, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback